The tables in this section are from Schatzberg AF, Cole JO, DeBattista C. Manual of Clinical Psychopharmacology Fifth edition. 2005 American Psychiatric Publishing Inc., Arlington, VA
Reprinted with permission.
Editors note: since initial publication of tables reprinted from the Manual of Clinical Psychopharmacology, additional medications have FDA approval. Some of these recent indications include: clonazepam approved for panic disorder; risperidone, quetiapine, ziprasidone, and aripiprazole approved for acute mania. Olanzepine-fluoxetine combination and quetiapine approved for bipolar depression. Lamotrigine approved for the prevention of depression.